Why can’t kids get Covid-19 vaccines? Is there hope for biotech penny stocks? And when are feces medicine?
We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, pediatric cancer advocate Nancy Goodman joins us to discuss why she believes Covid-19 vaccine trials need to be sped up for teens and children. Then, Wall Street Journal reporter Greg Zuckerman calls in to explain the unlikely story behind Novavax, a former biotech penny stock now on the verge of making history. Finally, we embark on a lightning round, featuring quick takes on the confirmation process for a new health secretary and the future of therapeutic stool.
For more on what we cover, here’s the Novavax story; here’s more on HHS secretary confirmation; here’s the news on fecal transplantation; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the coronavirus pandemic.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].